Streetbeat News

Analyst Ratings

LNC

Analysts have provided indifferent to somewhat bearish ratings for Lincoln National (NYSE:LNC) in the last quarter. According to 8 analysts, Lincoln National has an average 12-month price target of $25.75, with a high of $32.00 and a low of $18.00. This average price target has increased by 7.29% over the past month.

Portfolio Pulse from Benzinga Insights

October 02, 2023 | 8:00 pm

TNDM

Tandem Diabetes Care (NASDAQ:TNDM) has received mixed analyst ratings in the last quarter, with 1 bullish, 2 somewhat bullish, and 6 indifferent. The average 12-month price target for the company is $35.89, a 17.17% decrease from the previous average of $43.33.

Portfolio Pulse from Benzinga Insights

October 02, 2023 | 8:00 pm

MCD

In the last quarter, McDonald's (NYSE:MCD) received mostly bullish ratings from analysts, with an average 12-month price target of $328.08, a 2.52% increase from the previous average price target of $320.00. No bearish ratings were observed.

Portfolio Pulse from Benzinga Insights

October 02, 2023 | 8:00 pm

OKTA

In the last quarter, Okta (NASDAQ:OKTA) received 7 bullish, 6 somewhat bullish, and 10 indifferent ratings from analysts. The company's average 12-month price target is $92.87, with a high of $112.00 and a low of $75.00. This average price target has increased by 10.84% over the past month.

Portfolio Pulse from Benzinga Insights

October 02, 2023 | 8:00 pm

CELH

Over the past 3 months, 10 analysts have published their opinion on Celsius Holdings (NASDAQ:CELH) stock. The company has an average price target of $198.1 with a high of $250.00 and a low of $155.00. The average price target has increased by 17.02% over the past month.

Portfolio Pulse from Benzinga Insights

October 02, 2023 | 8:00 pm

WCN

Over the past 3 months, 6 analysts have published their opinion on Waste Connections (NYSE:WCN) stock. The average price target for the stock is $163.5, an increase of 1.71% from the previous average price target of $160.75. The ratings are generally positive with 3 bullish, 2 somewhat bullish, and 1 indifferent.

Portfolio Pulse from Benzinga Insights

October 02, 2023 | 8:00 pm

MDT

Medtronic Inc.'s (NYSE:MDT) stock price is currently at $78.44, after a 0.10% increase. However, the stock has decreased by 3.25% over the past month, and by 8.18% over the past year. The company's P/E ratio of 28.92 is lower than the aggregate P/E ratio of 69.81 in the Health Care Equipment & Supplies industry, which could indicate that the stock is undervalued or that shareholders do not expect the stock to perform better in the future.

Portfolio Pulse from Benzinga Insights

October 02, 2023 | 8:00 pm

JPM

JP Morgan Chase & Co CEO, Jamie Dimon, has expressed optimism about the potential of artificial intelligence (AI), stating that it will bring more benefits than drawbacks. He believes AI will replace some jobs but will also lead to significant advancements such as a 3.5-day work week and curing cancer. Dimon has previously called AI 'critical' to JPMorgan's future success and the company is currently hiring for thousands of AI-related positions.

Portfolio Pulse from Adam Eckert

October 02, 2023 | 7:54 pm

CCL

Carnival Corporation's (NYSE:CCL) shares are trading lower despite beating analyst consensus estimates for Q3 earnings and sales. The company also issued Q4 EBITDA guidance between $800 million and $900 million and expects Q4 occupancy of 101% or higher. Full-year 2023 EBITDA is anticipated to be between $4.1 billion and $4.2 billion with full-year 2023 occupancy expected to be 100% or higher. William Blair analyst Sharon Zackfia reinstated Carnival with an Outperform.

Portfolio Pulse from Ryan Gustafson

October 02, 2023 | 7:51 pm

CVS

HSY

MDLZ

NVO

PEP

SJM

The rise of obesity and diabetes drugs like Novo Nordisk's Wegovy and Ozempic is causing concerns about the future of the snacking industry. However, companies like J.M. Smucker's, Hershey Co, Mondelez International, and PepsiCo remain optimistic, citing the enduring popularity of snacks and the shift towards healthier options. High costs and limited insurance coverage for these drugs, with exceptions like CVS Health Corp's Aetna, also play a role.

Portfolio Pulse from Vandana Singh

October 02, 2023 | 7:47 pm